Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
Type:
Application
Filed:
January 27, 2020
Publication date:
September 24, 2020
Applicant:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
Type:
Grant
Filed:
December 1, 2017
Date of Patent:
March 24, 2020
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
Type:
Application
Filed:
December 1, 2017
Publication date:
August 2, 2018
Applicant:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
Type:
Grant
Filed:
October 29, 2010
Date of Patent:
January 2, 2018
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
Type:
Grant
Filed:
October 29, 2010
Date of Patent:
December 12, 2017
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
Abstract: The invention relates generally to compositions comprising dimethylsulfoxide (DMSO) and associated compounds in combination with one or more of the following: fructose 1,6-diphosphate, L-arginine, L-lysine, L-aspartate, and urea. Methods for treating traumatic brain injury, ischemic stroke, atherosclerosis, spinal cord trauma, and neurodegenerative illnesses are also provided.
Abstract: Several embodiments of the invention relate to devices for the removal of dimethyl sulfoxide (DMSO) or related compounds, or odors associated with DMSO or DMSO-related compounds. Several embodiments relate to methods of using the same. In several embodiments the devices include adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies.
Abstract: The invention relates generally to materials for facilitating the administration of dimethyl sulfoxide (DMSO) and related compounds. In one embodiment, the invention comprises a kit comprising items used for the safe and effective administration of DMSO. In another embodiment, the invention relates to indicating containers for holding or delivering DMSO.
Type:
Grant
Filed:
May 3, 2013
Date of Patent:
November 17, 2015
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Harvey L. Claussen, Colette Cozean, Jack De La Torre
Abstract: Several embodiments of the invention relate to devices for the removal of dimethyl sulfoxide (DMSO) or related compounds, or odors associated with DMSO or DMSO-related compounds. Several embodiments relate to methods of using the same. In several embodiments the devices include adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies.
Abstract: Several embodiments of the invention relate to methods for removing compositions comprising dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same. In several embodiments, systems including activated carbon filters, adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies are provided in order to perform said methods. In some embodiments the systems and methods facilitating the treatment of traumatic brain injury, ischemic stroke, atherosclerosis, spinal cord trauma, and neurodegenerative illnesses with compositions comprising DMSO.
Type:
Grant
Filed:
May 2, 2011
Date of Patent:
March 18, 2014
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Jesse Cozean, Colette Cozean, Efrain Gonzales, Stanley W. Jacob
Abstract: The invention relates generally to materials for facilitating the administration of dimethyl sulfoxide (DMSO) and related compounds. In one embodiment, the invention comprises a kit comprising items used for the safe and effective administration of DMSO. In another embodiment, the invention relates to indicating containers for holding or delivering DMSO.
Abstract: Several embodiments of the invention relate to systems and methods for removing compositions comprising dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same. In several embodiments, the systems include activated carbon filters, adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies. Methods for reducing the concentration of a DMSO metabolite, or the odors associated with said DMSO metabolite are provided in some embodiments. In some embodiments the systems and methods facilitating the treatment of traumatic brain injury, ischemic stroke, atherosclerosis, spinal cord trauma, and neurodegenerative illnesses with compositions comprising DMSO.
Type:
Grant
Filed:
May 2, 2011
Date of Patent:
July 9, 2013
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Jesse Cozean, Colette Cozean, Efrain Gonzales, Stanley W. Jacob
Abstract: Preferred embodiments of the invention relate to systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same. The systems include adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies.
Abstract: The invention relates generally to materials for facilitating the administration of dimethyl sulfoxide (DMSO) and related compounds. In one embodiment, the invention comprises a kit comprising items used for the safe and effective administration of DMSO. In another embodiment, the invention relates to indicating containers for holding or delivering DMSO.
Type:
Grant
Filed:
September 11, 2006
Date of Patent:
May 7, 2013
Assignee:
Abela Pharmaceuticals, Inc.
Inventors:
Harvey L. Claussen, Colette Cozean, Jack De La Torre
Abstract: Preferred embodiments of the invention relate to systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same. The systems include adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies.
Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.
Type:
Application
Filed:
October 29, 2010
Publication date:
February 21, 2013
Applicant:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
Abstract: Embodiments of the invention relate generally to formulations comprising dimethyl sulfoxide (DMSO) to treat behavioral disorders, communication delays, and developmental delays. Several formulations disclosed herein are useful for treating broad autism phenotype disorders, including autism spectrum disorders (e.g., autism).
Type:
Application
Filed:
March 31, 2011
Publication date:
January 17, 2013
Applicant:
ABELA PHARMACEUTICALS, INC.
Inventors:
Stanley Jacob, Jesse Cozean, Colette Cozean
Abstract: Preferred embodiments of the invention relate to systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same. The systems include adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies.
Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.
Type:
Application
Filed:
October 29, 2010
Publication date:
August 16, 2012
Applicant:
Abela Pharmaceuticals, Inc.
Inventors:
Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
Abstract: Several embodiments of the invention relate to systems and methods for removing compositions comprising dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same. In several embodiments, the systems include activated carbon filters, adsorbents, odor adsorbing fabrics, masks, clean air members and clean air supply assemblies. Methods for reducing the concentration of a DMSO metabolite, or the odors associated with said DMSO metabolite are provided in some embodiments. In some embodiments the systems and methods facilitating the treatment of traumatic brain injury, ischemic stroke, atherosclerosis, spinal cord trauma, and neurodegenerative illnesses with compositions comprising DMSO.
Type:
Application
Filed:
May 2, 2011
Publication date:
August 25, 2011
Applicant:
ABELA PHARMACEUTICALS, INC.
Inventors:
Jesse Cozean, Colette Cozean, Efrain Gonzales, Stanley W. Jacob